A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
- Status
- COMPLETED
- Phase
- PHASE4
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE2
AGN-242428 in the Treatment of Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
- Status
- TERMINATED
- Phase
- PHASE4
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis
- Status
- COMPLETED
- Phase
- NA
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4